News
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...
Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...
But Wegovy may be more effective for weight loss because it’s taken in higher doses than Ozempic. Here’s a run-through of how each medication works and its effectiveness for weight loss.
Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...
New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker. The maker of Wegovy is claiming the weight loss drug can ...
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.
WEIGHT-LOSS drugs can be a silver bullet for some trying to shed the pounds after years of failure with fad diets and exercise routines. But dodgy vendors selling potentially deadly fake jabs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback